SUNHERE's shareholder FOSUN PHARMA plans to reduce its holdings by no more than 3%
I'm PortAI, I can summarize articles.
According to the announcement from Dolphin Research, SUNHERE announced that its shareholder Shanghai FOSUN PHARMA Industrial Development Co., Ltd. (hereinafter referred to as "FOSUN PHARMA") intends to reduce its holdings of the company's shares by no more than 6.9787 million shares, or no more than 3% of the company's total share capital, through centralized bidding and block trading within 90 days after 15 trading days from the date of the announcement (from November 24, 2025, to February 21, 2026)
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments